MY134311A - Medicament with delayed active constituent release containing 1-dimethylamino-3-(3-methoxyphenyl)-2-methylpentan-3-ol - Google Patents
Medicament with delayed active constituent release containing 1-dimethylamino-3-(3-methoxyphenyl)-2-methylpentan-3-olInfo
- Publication number
- MY134311A MY134311A MYPI20031965A MYPI20031965A MY134311A MY 134311 A MY134311 A MY 134311A MY PI20031965 A MYPI20031965 A MY PI20031965A MY PI20031965 A MYPI20031965 A MY PI20031965A MY 134311 A MY134311 A MY 134311A
- Authority
- MY
- Malaysia
- Prior art keywords
- methylpentan
- methoxyphenyl
- dimethylamino
- released
- hours
- Prior art date
Links
- PZNRRUTVGXCKFC-UHFFFAOYSA-N 1-(dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol Chemical compound CN(C)CC(C)C(O)(CC)C1=CC=CC(OC)=C1 PZNRRUTVGXCKFC-UHFFFAOYSA-N 0.000 title abstract 9
- 239000000470 constituent Substances 0.000 title abstract 4
- 230000003111 delayed effect Effects 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title 1
- 239000011159 matrix material Substances 0.000 abstract 2
- 238000004090 dissolution Methods 0.000 abstract 1
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 1
- 229920001600 hydrophobic polymer Polymers 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10224108A DE10224108A1 (de) | 2002-05-29 | 2002-05-29 | 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY134311A true MY134311A (en) | 2007-12-31 |
Family
ID=29557413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20031965A MY134311A (en) | 2002-05-29 | 2003-05-28 | Medicament with delayed active constituent release containing 1-dimethylamino-3-(3-methoxyphenyl)-2-methylpentan-3-ol |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1507519B1 (enExample) |
| JP (1) | JP5459818B2 (enExample) |
| AR (1) | AR039900A1 (enExample) |
| AT (1) | ATE326218T1 (enExample) |
| AU (1) | AU2003238397A1 (enExample) |
| CA (1) | CA2488220C (enExample) |
| DE (2) | DE10224108A1 (enExample) |
| DK (1) | DK1507519T3 (enExample) |
| ES (1) | ES2263976T3 (enExample) |
| MY (1) | MY134311A (enExample) |
| PE (1) | PE20040529A1 (enExample) |
| PL (1) | PL218397B1 (enExample) |
| PT (1) | PT1507519E (enExample) |
| WO (1) | WO2003099267A1 (enExample) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
| US5032406A (en) * | 1989-02-21 | 1991-07-16 | Norwich Eaton Pharmaceuticals, Inc. | Dual-action tablet |
| US5582837A (en) * | 1992-03-25 | 1996-12-10 | Depomed, Inc. | Alkyl-substituted cellulose-based sustained-release oral drug dosage forms |
| JPH06172161A (ja) * | 1992-12-10 | 1994-06-21 | Shin Etsu Chem Co Ltd | 徐放性錠剤 |
| DE4329794C2 (de) * | 1993-09-03 | 1997-09-18 | Gruenenthal Gmbh | Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung |
| DE4426245A1 (de) * | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| JPH1017497A (ja) * | 1996-07-02 | 1998-01-20 | Takeda Chem Ind Ltd | 徐放性製剤およびその製造方法 |
| DE10059412A1 (de) * | 2000-11-30 | 2002-06-13 | Gruenenthal Gmbh | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz |
| DE10146275A1 (de) * | 2001-09-18 | 2003-04-24 | Gruenenthal Gmbh | Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz |
-
2002
- 2002-05-29 DE DE10224108A patent/DE10224108A1/de not_active Withdrawn
-
2003
- 2003-05-26 EP EP03732464A patent/EP1507519B1/de not_active Expired - Lifetime
- 2003-05-26 AU AU2003238397A patent/AU2003238397A1/en not_active Abandoned
- 2003-05-26 DE DE50303372T patent/DE50303372D1/de not_active Expired - Lifetime
- 2003-05-26 PL PL374186A patent/PL218397B1/pl unknown
- 2003-05-26 DK DK03732464T patent/DK1507519T3/da active
- 2003-05-26 JP JP2004506791A patent/JP5459818B2/ja not_active Expired - Fee Related
- 2003-05-26 AT AT03732464T patent/ATE326218T1/de not_active IP Right Cessation
- 2003-05-26 CA CA2488220A patent/CA2488220C/en not_active Expired - Fee Related
- 2003-05-26 PT PT03732464T patent/PT1507519E/pt unknown
- 2003-05-26 ES ES03732464T patent/ES2263976T3/es not_active Expired - Lifetime
- 2003-05-26 WO PCT/EP2003/005488 patent/WO2003099267A1/de not_active Ceased
- 2003-05-28 MY MYPI20031965A patent/MY134311A/en unknown
- 2003-05-29 PE PE2003000521A patent/PE20040529A1/es not_active Application Discontinuation
- 2003-05-29 AR ARP030101884A patent/AR039900A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE50303372D1 (de) | 2006-06-22 |
| EP1507519A1 (de) | 2005-02-23 |
| CA2488220A1 (en) | 2003-12-04 |
| JP5459818B2 (ja) | 2014-04-02 |
| DK1507519T3 (da) | 2006-08-28 |
| AR039900A1 (es) | 2005-03-09 |
| ATE326218T1 (de) | 2006-06-15 |
| WO2003099267A1 (de) | 2003-12-04 |
| PT1507519E (pt) | 2006-08-31 |
| PE20040529A1 (es) | 2004-08-24 |
| CA2488220C (en) | 2011-02-01 |
| EP1507519B1 (de) | 2006-05-17 |
| JP2005534640A (ja) | 2005-11-17 |
| AU2003238397A1 (en) | 2003-12-12 |
| PL218397B1 (pl) | 2014-11-28 |
| DE10224108A1 (de) | 2004-01-29 |
| PL374186A1 (en) | 2005-10-03 |
| ES2263976T3 (es) | 2006-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY127797A (en) | 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol-containing pharmaceutical composition with slow release of active indgredient | |
| EA200700049A1 (ru) | Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением | |
| WO2008107149A3 (de) | Darreichungsform mit erschwertem missbrauch | |
| EP2266542A3 (en) | Controlled release nanoparticulate compositions | |
| WO2007048219A3 (en) | Sustained drug release composition | |
| DE60321386D1 (de) | Pharmazeutische zubereitung zur modifizierten freisetzung | |
| PE20030399A1 (es) | Formas de administracion de propiverina o sus sales farmaceuticamente aceptables con liberacion prolongada de la sustancia activa | |
| BR0107874A (pt) | Implante farmacêutico para controlavelmente liberar uma droga, método para controlavelmente liberar uma droga em um indivìduo, e, método para preparar o implante | |
| HUP0003405A2 (hu) | Szabályozott hatóanyag-leadású, szublingvális vagy bukkális adagolású gyógyszerkészítmények | |
| MY148475A (en) | Controlled release preparations comprising tramadol and topiramate | |
| MX2008000099A (es) | Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones. | |
| WO2006056711A3 (fr) | Medicament oral a liberation modifiee d'au moins un principe actif sous forme multimicrocapsulaire | |
| WO2001047498A3 (en) | Hydrogel-driven layered drug dosage form comprising sertraline | |
| DE60124294D1 (de) | Proinsulin c-peptid enthaltende arzneizubereitung mit verzögerter wirkstofffreigabe | |
| MX2007015480A (es) | Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada. | |
| BR0007360A (pt) | Composição de liberação controlada | |
| WO2005009329A3 (de) | 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol enthaltendes arzneimittel mit verzögerter wirkstofffreisetzung | |
| BR0311327A (pt) | Composição farmacêutica contendo oxcarbazepina com liberação sustentada de um ingrediente ativo | |
| MXPA04001933A (es) | Composicion farmaceutica que comprende lumiracoxib. | |
| WO2002034267A8 (de) | Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen | |
| IL174830A0 (en) | Pellets containing venlafaxine hydrochloride, pharmaceutical compositions comprising them and processes for their preparation | |
| CA2415154A1 (en) | Modified release formulations of selective serotonin re-uptake inhibitors | |
| ATE476997T1 (de) | Zusammensetzung und dosierform mit einer festen oder halbfesten matrix | |
| WO2006008173A3 (en) | Pharmaceutical formulations for inhalation | |
| MY134311A (en) | Medicament with delayed active constituent release containing 1-dimethylamino-3-(3-methoxyphenyl)-2-methylpentan-3-ol |